Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations

被引：0
|
作者：
Yukiko Shimoda
Tatsuya Yoshida
Jun Miyakoshi
Masahiro Torasawa
Akiko Tateishi
Yuji Matsumoto
Ken Masuda
Yuki Shinno
Yusuke Okuma
Yasushi Goto
Hidehito Horinouchi
Noboru Yamamoto
Yuichiro Ohe
机构：
[1] National Cancer Center Hospital,Department of Thoracic Oncology
[2] National Cancer Center Hospital,Department of Experimental Therapeutics
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Non-small cell lung cancer; Sequential therapy; Dosing interval; Serious adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2613 / 2621
页数：8
相关论文
共 50 条
  • [31] Prevalence, Therapy and Tumor Response in Patients with Rheumatic Immune-related Adverse Events Following Immune Checkpoint Inhibitor Therapy: A Single-Centre Analysis
    Verspohl, Sophia
    Holderried, Tobias
    Behning, Charlotte
    Brossart, Peter
    Schaefer, Valentin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [32] The safety and efficacy of immune checkpoint inhibitor rechallenge after immune-related adverse events in stage IV NSCLC patients.
    Guo, Mengni
    Vanderwalde, Ari M.
    Yu, Xinhua
    Vidal, Gregory A.
    Tian, Gary G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
    Nguyen, Nga
    Wan, Guihong
    Ugwu-Dike, Pearl
    Alexander, Nora A.
    Raval, Neel
    Zhang, Shijia
    Jairath, Ruple
    Phillipps, Jordan
    Leung, Bonnie
    Roster, Katie
    Seo, Jayhyun
    Lu, Chenyue
    Tang, Kimberly
    Choi, Min Seok
    DeSimone, Mia S.
    Theodosakis, Nicholas
    Amadife, Munachimso
    Cox, Nevada
    Le, Thomas K.
    Liu, Feng
    Chen, Wenxin
    Bai, Xue
    Boland, Genevieve
    Liu, David
    Hurlbert, Marc S.
    LeBoeuf, Nicole
    Reynolds, Kerry L.
    Yu, Kun-Hsing
    Tsao, Hensin
    Asgari, Maryam
    Gusev, Alexander
    Kwatra, Shawn G.
    Semenov, Yevgeniy R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (06) : 1308 - 1316
  • [34] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY ARE ASSOCIATED WITH ENHANCED SURVIVAL AND DISEASE-SPECIFIC INCIDENCE
    Vick, Eric
    Abuali, Inas
    Kelleher, Andrew
    Ludvigsen, Sarah
    Moore, Nathanael
    Arias, Nicholas
    Gulati, Shuchi
    Wise-Draper, Trisha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A152 - A153
  • [35] Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanoma
    Shah, Payal
    Punekar, Salman R.
    Pavlick, Anna C.
    MELANOMA RESEARCH, 2021, 31 (03) : 242 - 248
  • [36] Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment
    Morales-Barrera, Rafael
    Villacampa, Guillermo
    Vidal, Natalia
    Figols, Mariona
    Giner, Julia
    Bonfill, Teresa
    Suarez, Cristina
    Diaz, Nely
    Mateo, Joaquin
    Gonzalez, Macarena
    Domenech, Montserrat
    Puente, Javier
    Carles, Joan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (12): : 3556 - 3564
  • [37] Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment
    Rafael Morales-Barrera
    Guillermo Villacampa
    Natalia Vidal
    Mariona Figols
    Julia Giner
    Teresa Bonfill
    Cristina Suárez
    Nely Díaz
    Joaquín Mateo
    Macarena González
    Montserrat Domenech
    Javier Puente
    Joan Carles
    Clinical and Translational Oncology, 2023, 25 : 3556 - 3564
  • [38] SOCIAL DRIVERS OF MAJOR ADVERSE CARDIAC EVENTS (MACE) IN PATIENTS WITH CANCER RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Arega, Enat
    Hutchins, Elizabeth
    Yang, Eric H.
    Stein-Merlob, Ashley
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) : 2872 - 2872
  • [39] Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy
    Lusa, Amanda
    Alvarez, Carolina
    Beem, Shruti Saxena
    Schwartz, Todd A.
    Ishizawar, Rumey
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [40] Management of the Top 10 Most Common Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy
    Schneider, Bryan J.
    Lacchetti, Christina
    Bollin, Kathryn
    JCO ONCOLOGY PRACTICE, 2022, 18 (06) : 431 - +
12345